New study to analyze Real-World use of iptacopan for rare kidney disease
NCT ID NCT07331259
First seen Jan 11, 2026 · Last updated May 13, 2026 · Updated 20 times
Summary
This study looks at medical records of 83 adults with C3 glomerulopathy (a rare kidney disease) who are taking the drug iptacopan. Researchers will describe patients' health history, lab results, and how their disease changes over a year. The goal is to learn more about the types of patients using this treatment and their outcomes in real-world settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for C3 GLOMERULOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.